Vaxart Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Steven Lo
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 3yrs |
Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Investors Give Vaxart, Inc. (NASDAQ:VXRT) Shares A 29% Hiding
Nov 16There's Reason For Concern Over Vaxart, Inc.'s (NASDAQ:VXRT) Massive 39% Price Jump
Aug 20An Intrinsic Calculation For Vaxart, Inc. (NASDAQ:VXRT) Suggests It's 26% Undervalued
Jun 15Here's Why Vaxart (NASDAQ:VXRT) Must Use Its Cash Wisely
Nov 08Vaxart (NASDAQ:VXRT) Will Have To Spend Its Cash Wisely
Jun 30Vaxart: The Market Still Isn't Buying Oral Vaccine Thesis
Sep 09Ray Stapleton joins Vaxart as CTO
Aug 31Vaxart shareholders approve proposal to increase number of shares
Aug 05Vaxart continues to lobby shareholders to vote to increase number of shares
Jul 29Vaxart oral COVID-19 pill vaccine candidate induces long-lasting antibodies against SARS-CoV-2
Jul 20Vaxart says recent CRO agreement 'may be integral' to oral COVID vaccine success
Jul 07Vaxart: A Unique Vaccine Concern
Jun 14Vaxart: A Speculative Biotech With Potential As Covid-19 Play And Oral Vaccine Platform
Feb 26Vaxart: Investment Case For An Oral COVID Vaccine Not So Hard To Swallow
Dec 09Vaxart: Differentiated Covid Oral Route Remains Viable
Nov 16Vaxart: A Close Look At Their COVID-19 Oral Tablet Vaccine Program
Oct 30CEO
Steven Lo (57 yo)
less than a year
Tenure
Mr. Steven Lo serves as President, CEO & Director of Vaxart, Inc. since March 18, 2024. He has been Director at Zosano Pharma Corporation since October 2019 and serves as its President and Chief Executive...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Senior VP & Chief Scientific Officer | 14.8yrs | US$1.14m | 0.10% $ 145.0k | |
Chief Medical Officer | 3.3yrs | US$1.17m | 0.063% $ 88.2k | |
President | less than a year | no data | no data | |
CFO, Principal Financial Officer & Principal Accounting Officer | 1.9yrs | no data | 0.036% $ 49.8k | |
Chief Technology Officer | 2.3yrs | no data | no data | |
Senior VP & General Counsel | 2.8yrs | no data | 0.050% $ 69.3k | |
Senior Vice President of Clinical Development & Project Management | 4.7yrs | no data | no data | |
Senior Vice President of Quality | 3.8yrs | no data | no data |
3.0yrs
Average Tenure
56.5yo
Average Age
Experienced Management: VXRT's management team is considered experienced (3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | less than a year | no data | no data | |
Independent Director | 5.1yrs | US$92.26k | 0.0081% $ 11.3k | |
Member of Scientific & Clinical Advisory Board | 3.3yrs | no data | no data | |
Independent Director | 2.3yrs | US$89.08k | 0.011% $ 15.0k | |
Independent Chairman of the Board | 6.8yrs | US$109.57k | 0.29% $ 410.6k | |
Member of Scientific & Clinical Advisory Board | 3.3yrs | no data | no data | |
Independent Director | 3.6yrs | US$93.72k | 0.0065% $ 9.0k | |
Member of Scientific & Clinical Advisory Board | 3.3yrs | no data | no data | |
Independent Director | 2.3yrs | US$94.76k | 0.023% $ 32.0k | |
Member of Scientific & Clinical Advisory Board | 3.3yrs | no data | no data | |
Member of Scientific & Clinical Advisory Board | 3.3yrs | no data | no data | |
Member of Scientific & Clinical Advisory Board | 3.3yrs | no data | no data |
3.3yrs
Average Tenure
66yo
Average Age
Experienced Board: VXRT's board of directors are considered experienced (3.3 years average tenure).